Literature DB >> 16566583

Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains.

Lubka T Roumenina1, Marieta M Ruseva, Alexandra Zlatarova, Rohit Ghai, Martin Kolev, Neli Olova, Mihaela Gadjeva, Alok Agrawal, Barbara Bottazzi, Alberto Mantovani, Kenneth B M Reid, Uday Kishore, Mihaela S Kojouharova.   

Abstract

C1q is the first subcomponent of the classical complement pathway that can interact with a range of biochemically and structurally diverse self and nonself ligands. The globular domain of C1q (gC1q), which is the ligand-recognition domain, is a heterotrimeric structure composed of the C-terminal regions of A (ghA), B (ghB), and C (ghC) chains. The expression and functional characterization of ghA, ghB, and ghC modules have revealed that each chain has specific and differential binding properties toward C1q ligands. It is largely considered that C1q-ligand interactions are ionic in nature; however, the complementary ligand-binding sites on C1q and the mechanisms of interactions are still unclear. To identify the residues on the gC1q domain that are likely to be involved in ligand recognition, we have generated a number of substitution mutants of ghA, ghB, and ghC modules and examined their interactions with three selected ligands: IgG1, C-reactive protein (CRP), and pentraxin 3 (PTX3). Our results suggest that charged residues belonging to the apex of the gC1q heterotrimer (with participation of all three chains) as well as the side of the ghB are crucial for C1q binding to these ligands, and their contribution to each interaction is different. It is likely that a set of charged residues from the gC1q surface participate via different ionic and hydrogen bonds with corresponding residues from the ligand, instead of forming separate binding sites. Thus, a recently proposed model suggesting the rotation of the gC1q domain upon ligand recognition may be extended to C1q interaction with CRP and PTX3 in addition to IgG1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16566583      PMCID: PMC3874390          DOI: 10.1021/bi052646f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  41 in total

Review 1.  C1q: structure, function, and receptors.

Authors:  U Kishore; K B Reid
Journal:  Immunopharmacology       Date:  2000-08

2.  Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains.

Authors:  Uday Kishore; Sanjeev K Gupta; Michael V Perdikoulis; Mihaela S Kojouharova; Britta C Urban; Kenneth B M Reid
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

3.  The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties.

Authors:  Christine Gaboriaud; Jordi Juanhuix; Arnaud Gruez; Monique Lacroix; Claudine Darnault; David Pignol; Denis Verger; Juan C Fontecilla-Camps; Gérard J Arlaud
Journal:  J Biol Chem       Date:  2003-09-05       Impact factor: 5.157

4.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

Review 5.  Structural and functional anatomy of the globular domain of complement protein C1q.

Authors:  Uday Kishore; Rohit Ghai; Trevor J Greenhough; Annette K Shrive; Domenico M Bonifati; Mihaela G Gadjeva; Patrick Waters; Mihaela S Kojouharova; Trinad Chakraborty; Alok Agrawal
Journal:  Immunol Lett       Date:  2004-09       Impact factor: 3.685

6.  The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules.

Authors:  N C Hughes-Jones; B Gardner
Journal:  Immunology       Date:  1978-03       Impact factor: 7.397

7.  Gross conformation of C1q: a subcomponent of the first component of complement.

Authors:  P A Liberti; S M Paul
Journal:  Biochemistry       Date:  1978-05-16       Impact factor: 3.162

Review 8.  C1q and tumor necrosis factor superfamily: modularity and versatility.

Authors:  Uday Kishore; Christine Gaboriaud; Patrick Waters; Annette K Shrive; Trevor J Greenhough; Kenneth B M Reid; Robert B Sim; Gerard J Arlaud
Journal:  Trends Immunol       Date:  2004-10       Impact factor: 16.687

9.  Localization of ligand-binding sites on human C1q globular head region using recombinant globular head fragments and single-chain antibodies.

Authors:  Mihaela S Kojouharova; Ivanka G Tsacheva; Magdalena I Tchorbadjieva; Kenneth B M Reid; Uday Kishore
Journal:  Biochim Biophys Acta       Date:  2003-11-03

10.  Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction.

Authors:  Mihaela S Kojouharova; Mihaela G Gadjeva; Ivanka G Tsacheva; Aleksandra Zlatarova; Liubka T Roumenina; Magdalena I Tchorbadjieva; Boris P Atanasov; Patrick Waters; Britta C Urban; Robert B Sim; Kenneth B M Reid; Uday Kishore
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more
  48 in total

1.  Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing.

Authors:  Ankit Mahendra; Xingyu Yang; Shaza Abnouf; Jay R T Adolacion; Daechan Park; Sanam Soomro; Jason Roszik; Cristian Coarfa; Gabrielle Romain; Keith Wanzeck; S Louis Bridges; Amita Aggarwal; Peng Qiu; Sandeep K Agarwal; Chandra Mohan; Navin Varadarajan
Journal:  Arthritis Rheumatol       Date:  2019-02-23       Impact factor: 10.995

2.  Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo.

Authors:  Sheri L Peterson; Hal X Nguyen; Oscar A Mendez; Aileen J Anderson
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

3.  Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.

Authors:  Lee Aun Tan; Andrew C Yang; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2011-05-15       Impact factor: 14.870

4.  Heme interacts with c1q and inhibits the classical complement pathway.

Authors:  Lubka T Roumenina; Maria Radanova; Boris P Atanasov; Krastio T Popov; Srinivas V Kaveri; Sébastien Lacroix-Desmazes; Véronique Frémeaux-Bacchi; Jordan D Dimitrov
Journal:  J Biol Chem       Date:  2011-03-22       Impact factor: 5.157

Review 5.  Infections of people with complement deficiencies and patients who have undergone splenectomy.

Authors:  Sanjay Ram; Lisa A Lewis; Peter A Rice
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 6.  C1q: A fresh look upon an old molecule.

Authors:  Nicole M Thielens; Francesco Tedesco; Suzanne S Bohlson; Christine Gaboriaud; Andrea J Tenner
Journal:  Mol Immunol       Date:  2017-06-07       Impact factor: 4.407

Review 7.  The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.

Authors:  Alok Agrawal; Madathilparambil V Suresh; Sanjay K Singh; Donald A Ferguson
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2008-12       Impact factor: 2.895

8.  Human SAP is a novel peptidoglycan recognition protein that induces complement-independent phagocytosis of Staphylococcus aureus.

Authors:  Jang-Hyun An; Kenji Kurokawa; Dong-Jun Jung; Min-Jung Kim; Chan-Hee Kim; Yukari Fujimoto; Koichi Fukase; K Mark Coggeshall; Bok Luel Lee
Journal:  J Immunol       Date:  2013-08-21       Impact factor: 5.422

9.  Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides.

Authors:  Sarika Agarwal; Shreekant Vasudhev; Rosane B DeOliveira; Sanjay Ram
Journal:  J Immunol       Date:  2014-07-11       Impact factor: 5.422

Review 10.  Possible novel biomarkers of organ involvement in systemic lupus erythematosus.

Authors:  Dinglei Su; Rui Liu; Xia Li; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2014-03-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.